Alpha 2.0
Login Register
» Articles » PMID: 2017233

Immunosuppression in Aplastic Anemia--postponing the Inevitable?

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1991 May 9
PMID 2017233
Citations 5
Authors
M A Moore
H Castro-Malaspina
Affiliations
Soon will be listed here.
Citing Articles

The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.

Piekarska A, Pawelec K, Szmigielska-Kaplon A, Ussowicz M Front Immunol. 2024; 15:1378432.

PMID: 38646536 PMC: 11026616. DOI: 10.3389/fimmu.2024.1378432.

Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?.

Bacigalupo A Haematologica. 2023; 108(12):3199-3200.

PMID: 37439355 PMC: 10690898. DOI: 10.3324/haematol.2023.283523.

Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.

Drexler B, Zurbriggen F, Diesch T, Viollier R, Halter J, Heim D Ann Hematol. 2020; 99(11):2529-2538.

PMID: 32948913 PMC: 7536165. DOI: 10.1007/s00277-020-04271-4.

Felbamate in epilepsy therapy: evaluating the risks.

Pellock J Drug Saf. 1999; 21(3):225-39.

PMID: 10487399 DOI: 10.2165/00002018-199921030-00006.

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Faulds D, Goa K, Benfield P Drugs. 1993; 45(6):953-1040.

PMID: 7691501 DOI: 10.2165/00003495-199345060-00007.